With 64 rushing yards on Sunday, Derrick Henry passed Marcus Allen, Edgerrin James and Marshall Faulk for the 12th-most rushing yards in NFL history. Henry needs just 19 rushing yards on Thanksgiving ...

NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of ...

Class Notes are back! Have you recently celebrated a marriage, welcomed a child, advanced in your career or achieved another milestone? We’d love to hear from you. Please send your life update (in 100 ...

The haters gonna hate, hate, hate, hate, hate. Taylor Swift’s latest album, “The Life of a Showgirl,” is a pop triumph. Released on Friday, “The Life of a Showgirl” is Swift’s 12th studio album. The ...

The biotech published a readout from a clinical study of an antidepressant drug. It is developing the medication in collaboration with a privately held peer. That drug, tagged BPL-003 by Atai, is an ...

The life sciences industry is at a turning point. The pressures are mounting—shorten development timelines, meet regulatory demands and deliver therapies that patients actually need in the real world.

Harvard economist Roland Fryer discovered something remarkable while studying the Harlem Children's Zone. They had eliminated the racial achievement gap in math and cut it by a third in reading. But ...

As global scientific and regulatory landscapes shift, companies across the life sciences sector are under growing pressure to adapt. For Phenomenex, a global leader in separation sciences, that means ...

Shares of 180 Life Sciences climbed after the company sold $156 million in convertible notes in order to load up its ether reserves. The stock was up 11% at $3.32 in afternoon trading. Shares have now ...

PALO ALTO - 180 Life Sciences Corp. (NASDAQ:ATNF), which plans to rebrand as ETHZilla, announced Monday it has sold approximately $156 million in senior secured convertible notes due 2028 to an ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Frazier Life Sciences (FLS), a longstanding investment firm focused on innovative therapeutics, today announced the closing of Frazier Life Sciences XII, L.P. (FLS ...